ROOPA KORNI: Open Payments
NPI 1629272810 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,371 in 77 payments from 12 companies in 2025. Trend: 2023 $1,499 · 2024 $1,564 · 2025 $1,371
Food & beverage: $1,371
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $296 |
| ABBVIE INC. | 14 | $201 |
| AstraZeneca Pharmaceuticals LP | 9 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $181 |
| Amgen Inc. | 13 | $150 |
| Exact Sciences Corporation | 5 | $102 |
| Lilly USA, LLC | 4 | $93 |
| PFIZER INC. | 3 | $67 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Lundbeck LLC | 1 | $20 |
Products named: CAPLYTA, OTEZLA, VRAYLAR, Rybelsus, Ozempic, BREZTRI, Cologuard Collection Kit, MOUNJARO.
Industry payments across NY — which companies pay providers there.
